The rise of copyright’s blockbuster initially sparked a period of growth for the drug industry, but recent shifts present a complicated picture for shareholders. Off-patent alternatives are eroding profits, and https://barryxmik585353.angelinsblog.com/39979429/sildenafil-and-big-pharma-a-risky-play